Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: The Atherosclerosis Risk in Communities (ARIC) study

Metabolism: Clinical and Experimental

Volumn 62, Issue 1, 2013, Pages 100-108

  Chow, Lisa S ^a   Li, Shuzhen ^b   Eberly, Lynn E ^b   Seaquist, Elizabeth R ^a   Eckfeldt, John H ^a   Hoogeveen, Ron C ^c   Couper, David J ^d   Steffen, Lyn M ^b   Pankow, James S ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d IL   (United States)

Author keywords

Fatty acid ratio; Prospective study; Type 2 Diabetes

Indexed keywords

ACYL COENZYME A DESATURASE 1; CARBOHYDRATE; CHOLESTEROL ESTER; FATTY ACID; MONOUNSATURATED FATTY ACID; PHOSPHOLIPID; SATURATED FATTY ACID; STEAROYL COENZYME A DESATURASE 1; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; DIABETES MELLITUS; DIETARY INTAKE; EDUCATIONAL STATUS; ENZYME ACTIVITY; FAMILY HISTORY; FATTY ACID BLOOD LEVEL; FEMALE; FIBER; FOLLOW UP; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; WAIST HIP RATIO;

CHOLESTEROL ESTERS; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STEAROYL-COA DESATURASE; UNITED STATES;

EID: 84870912311     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.06.004     Document Type: Article

References (40)

1. J.S. Pankow, B.B. Duncan, and M.I. Schmidt Fasting plasma free fatty acids and risk of type 2 diabetes - The Atherosclerosis Risk in Communities study Diabetes Care 27 1 2004 77 82
2. L. Wang, A.R. Folsom, and Z.J. Zheng Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study Am J Clin Nutr 78 1 2003 91 98
3. J. Ma, A.R. Folsom, and E. Shahar Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults Am J Clin Nutr 62 3 1995 564 571
4. L. Hodson, C.M. Skeaff, and B.A. Fielding Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake Prog Lipid Res 47 5 2008 348 380
5. J.M. Ntambi, and M. Miyazaki Regulation of stearoyl-CoA desaturases and role in metabolism Prog Lipid Res 43 2 2004 91 104
6. M.T. Flowers, and J.M. Ntambi Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism Curr Opin Lipidol 19 3 2008 248 256
7. S. Schenk, and J.F. Horowitz Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance J Clin Invest 117 6 2007 1690 1698
8. J.M. Ntambi, M. Miyazaki, and J.P. Stoehr Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity Proc Natl Acad Sci U S A 99 17 2002 11482 11486
9. S.M. Rahman, A. Dobrzyn, and P. Dobrzyn Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle Proc Natl Acad Sci U S A 100 19 2003 11110 11115
10. P. Dobrzyn, A. Dobrzyn, and M. Miyazaki Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver Proc Natl Acad Sci U S A 101 17 2004 6409 6414
11. S.K. Das, and R. Chakrabarti Antiobesity therapy: Emerging drugs and targets Curr Med Chem 13 12 2006 1429 1460
12. G.Q. Jiang, Z.H. Li, and F. Liu Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1 J Clin Invest 115 4 2005 1030 1038
13. R. Gutierrez-Juarez, A. Pocai, and C. Mulas Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance J Clin Invest 116 6 2006 1686 1695
14. A. Peter, A. Cegan, and S. Wagner Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios Clin Chem 55 12 2009 2113 2120
15. A. Kotronen, T. Seppanen-Laakso, and J. Westerbacka Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum Obesity 18 5 2010 937 944
16. E. Warensjo, U. Riserus, and B. Vessby Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men Diabetologia 48 10 2005 1999 2005
17. U. Riserus, J. Arlov, and L. Berglund Long-term predictors of insulin resistance: Role of lifestyle and metabolic factors in middle-aged men Diabetes Care 30 11 2007 2928 2933
18. Y.E. Zhou, G.M. Egeland, and S.J. Meltzer The association of desaturase 9 and plasma fatty acid composition with insulin resistance-associated factors in female adolescents Metab Clin Exp 58 2 2009 158 166
19. P.S. Patel, S.J. Sharp, and E. Jansen Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort Am J Clin Nutr 92 5 2010 1214 1222
20. J. Kroger, V. Zietemann, and C. Enzenbach Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Am J Clin Nutr 93 1 2011 127 142
21. J. Ma, A.R. Folsom, and J.H. Eckfeldt Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters Am J Clin Nutr 62 3 1995 572 578
22. O.D. Williams The Atherosclerosis Risk in Communities (ARIC) Study - Design and Objectives Am J Epidemiol 129 4 1989 687 702
23. B.B. Duncan, M.I. Schmidt, and J.S. Pankow Low-grade systemic inflammation and the development of type 2 diabetes - The Atherosclerosis Risk in Communities Study Diabetes 52 7 2003 1799 1805
24. W.R. Morrison, and L.M. Smith Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol J Lipid Res 5 4 1964 600 608
25. M.T. Flowers The delta9 fatty acid desaturation index as a predictor of metabolic disease Clin Chem 55 12 2009 2071 2073
26. Investigators The ARIC The Atherosclerosis Risk in Communities (ARIC) Study: Design and Objectives Am J Epidemiol 129 4 1989 687 702
27. W.C. Willett, L. Sampson, and M.J. Stampfer Reproducibility and Validity of a Semiquantitative Food Frequency Questionnaire Am J Epidemiol 122 1 1985 51 65
28. J.A.H. Baecke, J. Burema, and J.E.R. Frijters A short questionnaire for the measurement of habitual physical activity in epidemiological studies Am J Clin Nutr 36 5 1982 936 942
29. A.R. Folsom, M. Szklo, and J. Stevens A Prospective Study of Coronary Heart Disease in Relation to Fasting Insulin, Glucose, and Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study Diabetes Care 20 6 1997 935 942
30. E. Bonora, F. Saggiani, and G. Targher Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity Diabetes Care 23 1 2000 57 63
31. G.J. Van Woudenbergh, A. Kuijsten, and C.J. Van der Kallen Comparison of fatty acid proportions in serum cholesteryl esters among people with different glucose tolerance status: The CoDAM study Nutr Metab Cardiovasc Dis 22 2 2012 133 140
32. A.M. Hodge, D.R. English, and K. O'Dea Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid Am J Clin Nutr 86 1 2007 189 197
33. J.B. Flowers, M.E. Rabaglia, and K.L. Schueler Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice Diabetes 56 5 2007 1228 1239
34. H.M. Cao, K. Gerhold, and J.R. Mayers Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism Cell 134 6 2008 933 944
35. D. Mozaffarian, H.M. Cao, and I.B. King Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes Am J Clin Nutr 92 6 2010 1350 1358
36. F. Amati, J.J. Dube, and E. Alvarez-Carnero Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 60 10 2011 2588 2597
37. B.C. Bergman, L. Perreault, and D.M. Hunerdosse Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes J Appl Physiol 108 5 2010 1134 1141
38. A. Yao-Borengasser, N. Rassouli, and V. Varma Stearoyl-Coenzyme A Desaturase 1 Gene Expression Increases after Pioglitazone Treatment and Is Associated with Peroxisomal Proliferator-Activated Receptor-gamma Responsiveness J Clin Endocrinol Metabol 93 11 2008 4431 4439
39. K. Mai, J. Andres, and T. Bobbert Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo Metabolism 61 1 2012 108 116
40. R.M. Oballa, L. Belair, and W.C. Black Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia J Med Chem 54 14 2011 5082 5096